Rikke Rosbjerg1,2, Robert Zachariae3, Dorte Gilså Hansen4, Inger Hoejris5, Saskia Duijts6, Nina Lykkegaard Gehr5, Irene Dyhrberg Andersen5,7, Merete Labriola8,9. 1. Department of Public Health, Aarhus University, Aarhus, Denmark. Rikke.Rosbjerg@stab.rm.dk. 2. DEFACTUM, Central Denmark Region, Denmark, P.P. Ørums Gade 11, 1.B, 8000, Aarhus, Denmark. Rikke.Rosbjerg@stab.rm.dk. 3. Unit for Psychooncology and Health Psychology, Department of Psychology, Aarhus University, Aarhus, Denmark. 4. Research Unit of General Practice, Institute of Public Health, University of Southern Denmark, Odense, Denmark. 5. Department of Oncology, Aarhus University Hospital, Aarhus, Denmark. 6. Amsterdam UMC, Vrije Universiteit Amsterdam, Department of Public and Occupational Health, Amsterdam Public Health research institute, Amsterdam, The Netherlands. 7. Department of Health and Care, Viby-Hoejbjerg, Aarhus Municipality, Aarhus, Denmark. 8. NORCE Norwegian Research Centre AS, Bergen, Norway. 9. Centre for Social Medicine, Frederiksberg and Bispebjerg Hospital, Copenhagen, Denmark.
Abstract
BACKGROUND: Numerous studies emphasize the positive effects of physical activity on health and well-being in cancer patients. The effects of physical activity on the working lives of cancer patients have received less attention. The aim of the present study was to examine the association between physical activity and work status in employees with cancer, and the mediating role of return to work self-efficacy (RTWSE) in this association. METHODS: Data from questionnaires (physical activity, RTWSE, performance status, sociodemographic), patient records, and Danish national registries (work status, education) were collected for 217 employees initiating chemotherapy for cancer. The associations of physical activity at baseline with work status at baseline and at twelve months follow-up, respectively, were estimated with logistic regression. The mediating role of RTWSE was investigated using the Sobel Goodmann test. RESULTS: Employees with moderate (> 30 min/day) or high (> 150 min/day) levels of current daily activity at baseline had significantly increased odds for working at baseline (OR = 2.83, 95%CI = 0.73-10.96 and OR = 6.13, 95%CI = 1.68-22.40, respectively) and at twelve months (OR = 3.90, 95%CI = 1.19-12.77 and OR = 3.43, 95%CI = 1.12-10.51, respectively), compared to sedentary employees. Likewise, employees, physically active in their leisure time (light or vigorous psychical activity) for 2-4 h/week or > 4 h/week of light activity at baseline, had increased odds for working at twelve months (OR range = 1.20 (95%CI = 0.40-3.61)-5.39(95%CI = 0.78-37.32)), compared to sedentary employees. RTWSE was not found to mediate the observed associations. CONCLUSIONS: Physical activity appears positively associated with work status in employees undergoing treatment for cancer in the twelve months period after initiating chemotherapy.
BACKGROUND: Numerous studies emphasize the positive effects of physical activity on health and well-being in cancerpatients. The effects of physical activity on the working lives of cancerpatients have received less attention. The aim of the present study was to examine the association between physical activity and work status in employees with cancer, and the mediating role of return to work self-efficacy (RTWSE) in this association. METHODS: Data from questionnaires (physical activity, RTWSE, performance status, sociodemographic), patient records, and Danish national registries (work status, education) were collected for 217 employees initiating chemotherapy for cancer. The associations of physical activity at baseline with work status at baseline and at twelve months follow-up, respectively, were estimated with logistic regression. The mediating role of RTWSE was investigated using the Sobel Goodmann test. RESULTS: Employees with moderate (> 30 min/day) or high (> 150 min/day) levels of current daily activity at baseline had significantly increased odds for working at baseline (OR = 2.83, 95%CI = 0.73-10.96 and OR = 6.13, 95%CI = 1.68-22.40, respectively) and at twelve months (OR = 3.90, 95%CI = 1.19-12.77 and OR = 3.43, 95%CI = 1.12-10.51, respectively), compared to sedentary employees. Likewise, employees, physically active in their leisure time (light or vigorous psychical activity) for 2-4 h/week or > 4 h/week of light activity at baseline, had increased odds for working at twelve months (OR range = 1.20 (95%CI = 0.40-3.61)-5.39(95%CI = 0.78-37.32)), compared to sedentary employees. RTWSE was not found to mediate the observed associations. CONCLUSIONS: Physical activity appears positively associated with work status in employees undergoing treatment for cancer in the twelve months period after initiating chemotherapy.
Entities:
Keywords:
Cancer; Physical activity; Return to work; Self-efficacy; Work status
Authors: Laurien M Buffart; Joeri Kalter; Maike G Sweegers; Kerry S Courneya; Robert U Newton; Neil K Aaronson; Paul B Jacobsen; Anne M May; Daniel A Galvão; Mai J Chinapaw; Karen Steindorf; Melinda L Irwin; Martijn M Stuiver; Sandi Hayes; Kathleen A Griffith; Alejandro Lucia; Ilse Mesters; Ellen van Weert; Hans Knoop; Martine M Goedendorp; Nanette Mutrie; Amanda J Daley; Alex McConnachie; Martin Bohus; Lene Thorsen; Karl-Heinz Schulz; Camille E Short; Erica L James; Ron C Plotnikoff; Gill Arbane; Martina E Schmidt; Karin Potthoff; Marc van Beurden; Hester S Oldenburg; Gabe S Sonke; Wim H van Harten; Rachel Garrod; Kathryn H Schmitz; Kerri M Winters-Stone; Miranda J Velthuis; Dennis R Taaffe; Willem van Mechelen; Marie-José Kersten; Frans Nollet; Jennifer Wenzel; Joachim Wiskemann; Irma M Verdonck-de Leeuw; Johannes Brug Journal: Cancer Treat Rev Date: 2016-12-05 Impact factor: 12.111
Authors: Angela G E M de Boer; Taina Taskila; Anneli Ojajärvi; Frank J H van Dijk; Jos H A M Verbeek Journal: JAMA Date: 2009-02-18 Impact factor: 56.272
Authors: Saskia F A Duijts; Martine P van Egmond; Evelien Spelten; Peter van Muijen; Johannes R Anema; Allard J van der Beek Journal: Psychooncology Date: 2013-12-23 Impact factor: 3.894
Authors: Sara Mijwel; Anna Jervaeus; Kate A Bolam; Jessica Norrbom; Jonas Bergh; Helene Rundqvist; Yvonne Wengström Journal: J Cancer Surviv Date: 2019-03-25 Impact factor: 4.442
Authors: Lis Adamsen; Morten Quist; Christina Andersen; Tom Møller; Jørn Herrstedt; Dorte Kronborg; Marie T Baadsgaard; Kirsten Vistisen; Julie Midtgaard; Birgitte Christiansen; Maria Stage; Morten T Kronborg; Mikael Rørth Journal: BMJ Date: 2009-10-13